Fortress Biotech, Inc. (FBIO)

Fortress Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	57.26	80.93	178.27	305.74	233.35
Cash & Short-Term Investments	57.26	80.93	178.27	305.74	233.35
Cash Growth	-29.24%	-54.60%	-41.69%	31.02%	70.51%
Accounts Receivable	10.23	15.22	28.21	23.11	23.93
Other Receivables	0.17	0.17	0.14	0.68	0.74
Receivables	10.4	15.39	28.35	23.79	24.67
Inventory	14.43	10.21	14.16	9.86	1.4
Prepaid Expenses	7.11	10.5	9.66	7.07	6.72
Other Current Assets	1.17	-	-	-	-
Total Current Assets	90.37	117.02	230.43	346.46	266.15
Property, Plant & Equipment	17.12	23.5	33.01	34.07	32.41
Long-Term Investments	-	-	-	-	17.57
Other Intangible Assets	31.86	20.29	27.2	12.55	14.63
Other Long-Term Assets	4.87	6.72	3.66	3.42	2.66
Total Assets	144.22	167.53	294.3	396.5	333.41
Accounts Payable	31.64	34.81	57.24	47.43	11.41
Accrued Expenses	30.74	34.68	36.51	39.99	31.26
Short-Term Debt	-	3.93	5	0.81	-
Current Portion of Long-Term Debt	0.63	3	7.24	4.51	4.52
Current Portion of Leases	2.62	2.52	2.45	2.1	1.85
Current Income Taxes Payable	0.93	0.84	0.72	0.35	0.14
Current Unearned Revenue	-	-	-	2.61	-
Other Current Liabilities	4.84	5.13	18.55	3.24	2.58
Total Current Liabilities	71.4	84.91	127.72	101.04	51.76
Long-Term Debt	57.96	60.86	93.14	46.56	59.81
Long-Term Leases	14.75	18.28	21.57	20.99	22.89
Other Long-Term Liabilities	1.76	1.89	1.85	2.03	1.95
Total Liabilities	145.87	165.94	244.28	170.63	136.41
Common Stock	0.03	0.02	0.01	0.1	0.1
Additional Paid-In Capital	763.57	717.4	675.94	656.03	583
Retained Earnings	-740.87	-694.87	-634.23	-547.46	-482.76
Total Common Equity	22.73	22.54	41.72	108.67	100.34
Minority Interest	-24.38	-20.96	8.3	117.2	96.66
Shareholders' Equity	-1.64	1.59	50.03	225.88	197
Total Liabilities & Equity	144.22	167.53	294.3	396.5	333.41
Total Debt	75.96	88.59	129.4	74.98	89.08
Net Cash (Debt)	-18.7	-7.67	48.87	230.77	144.28
Net Cash Growth	-	-	-78.82%	59.95%	564.37%
Net Cash Per Share	-0.90	-0.95	8.25	42.37	30.06
Filing Date Shares Outstanding	29.53	19.23	8.65	6.97	6.33
Total Common Shares Outstanding	27.91	15.09	7.37	6.76	6.33
Working Capital	18.97	32.11	102.72	245.42	214.39
Book Value Per Share	0.81	1.49	5.66	16.07	15.86
Tangible Book Value	-9.13	2.25	14.52	96.12	85.71
Tangible Book Value Per Share	-0.33	0.15	1.97	14.21	13.55
Buildings	0.58	0.58	0.58	0.58	-
Machinery	1.61	1.61	10.76	8.68	7.61
Construction In Progress	-	0.03	0.95	2.03	0.5
Leasehold Improvements	11	13.18	13.18	13.18	10.58

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q